{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:16:56Z","timestamp":1789665416245,"version":"4.0.1"},"reference-count":66,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Serum thyroglobulin (Tg) measured by immunometric assay (IMA) is prone to underestimation due to Tg autoantibody (TgAb) interference, often prompting reflex Tg measurement by liquid chromatography\/tandem mass spectrometry (MS) or radioimmunoassay (RIA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>IMA, MS, and RIA methodologies were used to measure serum Tg in TgAb-negative (TgAb\u2212) and TgAb-positive (TgAb+) patients with either distant metastatic differentiated thyroid cancer (DTC) or hyperthyroidism (HY)\u2014patients in whom a detectable serum Tg would be expected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>When TgAb was absent, all methodologies detected Tg in the sera of all DTC and HY patients and reported appropriate Tg trends and treatment responses for DTC patients with progressive distant metastatic disease, albeit with high between-method variability (&amp;gt;\u202f30% coefficient of variability). When TgAb was present, all methodologies reported lower serum Tg levels for both DTC and HY groups vs their respective TgAb\u2212 group. No Tg was detected by IMA or MS in \u223c50% TgAb+ DTC patients (6% had no Tg detected by RIA). Surprisingly, 5% of TgAb+ HY patients also had no Tg detected by IMA or MS. The inverse log TgAb\/log Tg correlations seen for the TgAb+ HY patient group with all methods suggested the presence of a TgAb-associated serum Tg-lowering effect.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>(i) Between-method Tg variability necessitates method continuity when monitoring the Tg trends of TgAb\u2212 DTC patients. (ii) The presence and concentration of TgAb appeared to have a lowering effect on serum Tg measured by all methodologies (IMA, MS, and RIA). (iii) Since the reliability of Tg measured in the presence of TgAb is often uncertain, the TgAb trend (measured by the same method) may be a useful surrogate DTC tumor marker.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae286","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T08:18:39Z","timestamp":1714465119000},"page":"3254-3263","source":"Crossref","is-referenced-by-count":15,"title":["Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS\/MS, and RIA"],"prefix":"10.1210","volume":"109","author":[{"given":"Ivana","family":"Petrovic","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Keck School of Medicine, University of Southern California , Los Angeles, CA 90033 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"LoPresti","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Keck School of Medicine, University of Southern California , Los Angeles, CA 90033 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Fatemi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Kaiser Permanente , Panorama City, CA 91402 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gianoukakis","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Lundquist Institute , Torrance, CA 90509 ,","place":["USA"]},{"name":"Division of Endocrinology, Diabetes and Metabolism, Harbor-UCLA Medical Center , Torrance, CA 90509 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Burman","sequence":"additional","affiliation":[{"name":"Endocrine Section, Medstar Washington Hospital Center , Washington, DC 20010 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane J","family":"Gomez-Lima","sequence":"additional","affiliation":[{"name":"Endocrine Section, Medstar Washington Hospital Center , Washington, DC 20010 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline T","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Keck School of Medicine, University of Southern California , Los Angeles, CA 90033 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3842-6595","authenticated-orcid":false,"given":"Carole Ann","family":"Spencer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Keck School of Medicine, University of Southern California , Los Angeles, CA 90033 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"issue":"1","key":"2024111803595958900_dgae286-B1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1586\/17446651.4.1.25","article-title":"Diagnosis and management of thyroid carcinoma: focus on serum thyroglobulin","volume":"4","author":"Grebe","year":"2009","journal-title":"Exp Rev Endocrinol Metab"},{"issue":"1","key":"2024111803595958900_dgae286-B2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1590\/2359-3997000000103","article-title":"Insights into the posttranslational structural heterogeneity of thyroglobulin and its role in the development, diagnosis, and management of benign and malignant thyroid diseases","volume":"60","author":"Xavier","year":"2016","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"2024111803595958900_dgae286-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"2024111803595958900_dgae286-B4","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1093\/ejendo\/lvad109","article-title":"Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus","volume":"189","author":"Giovanella","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2024111803595958900_dgae286-B5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ncpendmet0757","article-title":"Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer","volume":"4","author":"Spencer","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"8","key":"2024111803595958900_dgae286-B6","doi-asserted-by":"crossref","first-page":"E1074","DOI":"10.1210\/jc.2015-1967","article-title":"Thyroglobulin (Tg) testing revisited: Tg assays, TgAb assays, and correlation of results with clinical outcomes","volume":"100","author":"Netzel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024111803595958900_dgae286-B7","first-page":"977","article-title":"Monoclonal thyroglobulin autoantibodies: variable region analysis and epitope recognition","volume":"80","author":"Prentice","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024111803595958900_dgae286-B8","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1210\/jc.2005-0671","article-title":"Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas","volume":"90","author":"Spencer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024111803595958900_dgae286-B9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1515\/cclm-2014-0813","article-title":"Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges","volume":"53","author":"Giovanella","year":"2015","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"2024111803595958900_dgae286-B10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2265.1983.tb00036.x","article-title":"Should one measure serum thyroglobulin in the presence of anti-thyroglobulin antibodies?","volume":"19","author":"Black","year":"1983","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2024111803595958900_dgae286-B11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/eji.1830150311","article-title":"Various expression of a unique anti-human thyroglobulin antibody repertoire in normal state and autoimmune disease","volume":"15","author":"Ruf","year":"1985","journal-title":"Eur J Immunol"},{"issue":"2","key":"2024111803595958900_dgae286-B12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-8981(85)90161-5","article-title":"The effect of 125-I thyroglobulin tracer heterogeneity on serum Tg RIA measurement","volume":"153","author":"Spencer","year":"1985","journal-title":"Clin Chim Acta"},{"issue":"1-2","key":"2024111803595958900_dgae286-B13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jim.2009.06.003","article-title":"The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry","volume":"347","author":"Hoofnagle","year":"2009","journal-title":"J Immunol Methods"},{"issue":"8","key":"2024111803595958900_dgae286-B14","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2310\/JIM.0b013e318276deb4","article-title":"A novel mass spectrometry-based assay for the accurate measurement of thyroglobulin from patient samples containing antithyroglobulin autoantibodies","volume":"60","author":"Clarke","year":"2012","journal-title":"J Investig Med"},{"issue":"6","key":"2024111803595958900_dgae286-B15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1373\/clinchem.2012.195594","article-title":"Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies","volume":"59","author":"Kushnir","year":"2013","journal-title":"Clin Chem"},{"key":"2024111803595958900_dgae286-B16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clinms.2020.01.001","article-title":"More sensitivity is always better: measuring sub-clinical levels of serum thyroglobulin on a \u00b5LC-MS\/MS system","volume":"15","author":"Shuford","year":"2020","journal-title":"Clin Mass Spectrom"},{"issue":"17","key":"2024111803595958900_dgae286-B17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/BF01732185","article-title":"Increased heterogeneity of serum thyroglobulin in thyroid cancer patients as determined by monoclonal antibodies","volume":"64","author":"Heilig","year":"1986","journal-title":"Klin Wochenschr"},{"issue":"3","key":"2024111803595958900_dgae286-B18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/thy.1993.3.213","article-title":"Basal and thyrotropin-stimulated secretion rates of thyroglobulin from the human thyroid gland during surgery","volume":"3","author":"Tegler","year":"1993","journal-title":"Thyroid"},{"issue":"2","key":"2024111803595958900_dgae286-B19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1677\/joe.0.1700307","article-title":"Up to date with human thyroglobulin","volume":"170","author":"van de Graaf","year":"2001","journal-title":"J Endocrinol"},{"issue":"3","key":"2024111803595958900_dgae286-B20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/oxfordjournals.jbchem.a135344","article-title":"Properties of thyroglobulins from normal thyroid and thyroid tumor on a concanavalin-A-sepharose column","volume":"98","author":"Tarutani","year":"1985","journal-title":"J Biochem"},{"issue":"1-2","key":"2024111803595958900_dgae286-B21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cca.2006.12.017","article-title":"The clinical utility of Lens culinaris agglutinin-reactive thyroglobulin ratio in serum for distinguishing benign from malignant conditions of the thyroid","volume":"379","author":"Shimizu","year":"2007","journal-title":"Clin Chim Acta"},{"key":"2024111803595958900_dgae286-B22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fonc.2019.00380","article-title":"Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks","volume":"9","author":"Peixoto","year":"2019","journal-title":"Front Oncol"},{"issue":"3","key":"2024111803595958900_dgae286-B23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0303-7207(80)90108-2","article-title":"Conformational change of the thyroglobulin molecule induced by oxidation in vitro","volume":"17","author":"Berg","year":"1980","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2024111803595958900_dgae286-B24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1210\/jcem-57-6-1251","article-title":"Iodine content of serum thyroglobulin in normal individuals and patients with thyroid tumors","volume":"57","author":"Schneider","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024111803595958900_dgae286-B25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/thy.2008.0020","article-title":"Iodine content and distribution in extratumoral and tumor thyroid tissue analyzed with X-ray fluorescence and time-of-flight secondary ion mass spectrometry","volume":"18","author":"Hansson","year":"2008","journal-title":"Thyroid"},{"key":"2024111803595958900_dgae286-B26","first-page":"343","article-title":"Human thyroglobulin reference material (CRM 457) 2nd part: physicochemical characterization and certification","volume":"54","author":"Feldt-Rasmussen","year":"1996","journal-title":"Ann Biol Clin"},{"issue":"5","key":"2024111803595958900_dgae286-B27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MED.0000000000000092","article-title":"How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies","volume":"21","author":"Spencer","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"7","key":"2024111803595958900_dgae286-B28","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1210\/jc.2009-2109","article-title":"New insights into thyroglobulin pathophysiology revealed by the study of a family with congenital goiter","volume":"95","author":"Peteiro-Gonzalez","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024111803595958900_dgae286-B29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4155\/bio-2023-0149","article-title":"Challenges and current advances in the methodology of thyroglobulin measurements","volume":"16","author":"\u0110ori\u0107","year":"2024","journal-title":"Bioanalysis"},{"issue":"4","key":"2024111803595958900_dgae286-B30","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1210\/jc.2012-4172","article-title":"Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry","volume":"98","author":"Hoofnagle","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024111803595958900_dgae286-B31","first-page":"1121","article-title":"Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma","volume":"83","author":"Spencer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024111803595958900_dgae286-B32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/EJE-17-0663","article-title":"Early post-treatment risk stratification of differentiated thyroid cancer: comparison of three high-sensitive Tg assays","volume":"178","author":"Giovanella","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2024111803595958900_dgae286-B33","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/jc.2014-1203","article-title":"Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications","volume":"99","author":"Spencer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024111803595958900_dgae286-B34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0033-1349890","article-title":"Relationship between antithyroglobulin autoantibodies and thyroglobulin recovery rates using different thyroglobulin concentrations in the recovery buffer","volume":"45","author":"Verburg","year":"2013","journal-title":"Horm Metab Res"},{"issue":"5","key":"2024111803595958900_dgae286-B35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.beem.2013.07.003","article-title":"Thyroglobulin antibody (TgAb) methods\u2014strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer","volume":"27","author":"Spencer","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9-10","key":"2024111803595958900_dgae286-B36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.clinbiochem.2007.03.010","article-title":"Mutual interference between serum thyroglobulin and antithyroglobulin antibody in an automated chemiluminescent immunoassay","volume":"40","author":"Gao","year":"2007","journal-title":"Clin Biochem"},{"issue":"1","key":"2024111803595958900_dgae286-B37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/jcem-47-1-126","article-title":"Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies","volume":"47","author":"Schneider","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024111803595958900_dgae286-B38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/thy.2016.0210","article-title":"Thyroglobulin liquid chromatography-tandem mass spectrometry has a low sensitivity for detecting structural disease in patients with antithyroglobulin antibodies","volume":"27","author":"Azmat","year":"2017","journal-title":"Thyroid"},{"issue":"3","key":"2024111803595958900_dgae286-B39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s12020-020-02526-8","article-title":"The role of a new polyclonal competitive thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer with structural disease but low levels of serum thyroglobulin by immunometric and LC-MS\/MS methods","volume":"72","author":"Guastapaglia","year":"2021","journal-title":"Endocrine"},{"issue":"1","key":"2024111803595958900_dgae286-B40","doi-asserted-by":"crossref","first-page":"bvac169","DOI":"10.1210\/jendso\/bvac169","article-title":"Thyroglobulin assay interferences: clinical usefulness of mass-spectrometry methods","volume":"7","author":"Barbesino","year":"2022","journal-title":"J Endocr Soc"},{"issue":"3","key":"2024111803595958900_dgae286-B41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/ajcp\/aqw228","article-title":"Thyroglobulin antibody screen prior to mass spectrometry provides measurable cost savings and optimal laboratory utilization","volume":"147","author":"Powers","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"2024111803595958900_dgae286-B42","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1089\/thy.2019.0368","article-title":"Investigating antithyroglobulin antibody as a prognostic marker for differentiated thyroid cancer: a meta-analysis and systematic review","volume":"30","author":"Lee","year":"2020","journal-title":"Thyroid"},{"issue":"7","key":"2024111803595958900_dgae286-B43","doi-asserted-by":"crossref","first-page":"e230042","DOI":"10.1530\/ERC-23-0042","article-title":"Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosis","volume":"30","author":"Viola","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"2024111803595958900_dgae286-B44","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1210\/jc.2010-2762","article-title":"Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low\/undetectable serum Tg IMA values for patients with differentiated thyroid cancer","volume":"96","author":"Spencer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024111803595958900_dgae286-B45","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/jcem.80.2.7852506","article-title":"Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?","volume":"80","author":"Mariotti","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024111803595958900_dgae286-B46","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/thy.2013.0698","article-title":"Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies","volume":"24","author":"Durante","year":"2014","journal-title":"Thyroid"},{"issue":"1","key":"2024111803595958900_dgae286-B47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/105072503321086962","article-title":"Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease","volume":"13","author":"Baloch","year":"2003","journal-title":"Thyroid"},{"issue":"2","key":"2024111803595958900_dgae286-B48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0009-8981(85)90315-8","article-title":"Heterogeneity of 125-I labelled thyroglobulin preparations","volume":"151","author":"Spencer","year":"1985","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2024111803595958900_dgae286-B49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1398-9995.1982.tb01892.x","article-title":"Thyroid stimulating antibodies, thyroglobulin antibodies and serum proteins during treatment of Graves\u2019 disease with radioiodine or propylthiouracil","volume":"37","author":"Feldt-Rasmussen","year":"1982","journal-title":"Allergy"},{"issue":"6","key":"2024111803595958900_dgae286-B50","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4049\/jimmunol.98.6.1105","article-title":"The behaviour of autologous thyroglobulin in the circulation of rabbits immunized with either heterologous or altered homologous thyroglobulin","volume":"98","author":"Weigle","year":"1967","journal-title":"J Immunol"},{"issue":"1","key":"2024111803595958900_dgae286-B51","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imr.12392","article-title":"Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation","volume":"270","author":"Igawa","year":"2016","journal-title":"Immunol Rev"},{"issue":"3","key":"2024111803595958900_dgae286-B52","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/thy.2017.0052","article-title":"Effect of thyroglobulin autoantibodies on the metabolic clearance of Serum thyroglobulin","volume":"28","author":"Latrofa","year":"2018","journal-title":"Thyroid"},{"issue":"3","key":"2024111803595958900_dgae286-B53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/cancers12030625","article-title":"Preoperative serum thyroglobulin and its correlation with the burden and extent of differentiated thyroid cancer","volume":"12","author":"Kim","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2024111803595958900_dgae286-B54","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2265.2009.03693.x","article-title":"Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET\/CT","volume":"72","author":"Seo","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2024111803595958900_dgae286-B55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/jcem-61-2-343","article-title":"Monoclonal antibodies to thyroglobulin elucidate differences in protein structure of thyroglobulin in healthy individuals and those with papillary adenocarcinoma","volume":"61","author":"Kohno","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024111803595958900_dgae286-B56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jcem-67-1-161","article-title":"Altered immunoreactivity of thyroglobulin in thyroid disease","volume":"67","author":"Kim","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024111803595958900_dgae286-B57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9440(10)63642-5","article-title":"Proteomic and postproteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinomas","volume":"163","author":"Magro","year":"2003","journal-title":"Am J Pathol"},{"issue":"10","key":"2024111803595958900_dgae286-B58","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1349-7006.2007.00574.x","article-title":"Reduced sulfation of chondroitin sulfate in thyroglobulin derived from human papillary thyroid carcinomas","volume":"98","author":"Emoto","year":"2007","journal-title":"Cancer Sci"},{"issue":"1","key":"2024111803595958900_dgae286-B59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/08916939409014678","article-title":"Epitopes on thyroglobulin: a study of patients with thyroid disease","volume":"18","author":"Caturegli","year":"1994","journal-title":"Autoimmunity"},{"issue":"2","key":"2024111803595958900_dgae286-B60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1210\/jc.2007-1199","article-title":"Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies","volume":"93","author":"Latrofa","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024111803595958900_dgae286-B61","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2014-2725","article-title":"Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer","volume":"100","author":"Lupoli","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024111803595958900_dgae286-B62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/clin.1994.1115","article-title":"Immunoreactivity of multiple molecular forms of human thyroglobulin","volume":"72","author":"Saboori","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"issue":"11","key":"2024111803595958900_dgae286-B63","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.4049\/jimmunol.163.11.6244","article-title":"Peptides of human thyroglobulin reactive with sera of patients with autoimmune thyroid disease","volume":"163","author":"Saboori","year":"1999","journal-title":"J Immunol"},{"issue":"11","key":"2024111803595958900_dgae286-B64","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1373\/clinchem.2008.109652","article-title":"Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry","volume":"54","author":"Hoofnagle","year":"2008","journal-title":"Clin Chem"},{"issue":"5","key":"2024111803595958900_dgae286-B65","first-page":"428","article-title":"Discrimination of thyroglobulin from thyroid carcinoma tissue and that from benign thyroid tissues with use of competitive assay between lectin and anti-thyroglobulin antibody","volume":"55","author":"Shimizu","year":"2007","journal-title":"Rinsho Byori"},{"issue":"1","key":"2024111803595958900_dgae286-B66","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1186\/s13104-017-3050-6","article-title":"Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS\/MS measurements in an urban hospital","volume":"10","author":"Wheeler","year":"2017","journal-title":"BMC Res Notes"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae286\/57671745\/dgae286.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/12\/3254\/60680257\/dgae286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/12\/3254\/60680257\/dgae286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T04:00:38Z","timestamp":1731902438000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/12\/3254\/7659925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":66,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,4,30]]},"published-print":{"date-parts":[[2024,11,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae286","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,4,30]]}}}